(Q48586802)

13 February 2018

title

(131)I-chTNT-1/B mAb: tumour necrosis therapy for malignant astrocytic glioma (English)

1 reference

13 February 2018

author name string

William R Shapiro

1

1 reference

13 February 2018

Susan P Carpenter

2

1 reference

13 February 2018

Karen Roberts

3

1 reference

13 February 2018

Joseph S Shan

4

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

13 February 2018

Expert Opinion on Biological Therapy

published in

1 reference

13 February 2018

volume

6

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

539-545

1 reference

13 February 2018

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Stereotactic radiosurgery for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Glioblastoma cells release factors that disrupt blood-brain barrier features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Radiosurgery for brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.539

21 January 2018

Identifiers

DOI

10.1517/14712598.6.5.539

1 reference

13 February 2018

1 reference

13 February 2018